Preference of Dogs between Two Commercially Available Oral Formulations of Ectoparasiticide Containing Isoxazolines, Afoxolaner or Fluralaner
Read full paper at： http://www.scirp.org/journal/PaperInformation.aspx?PaperID=53934#.VNxjoCzQrzE Author(s) Lénaïg Halos 1* , Douglas S. Carithers 2 , Ruchika Solanki 2 , Heather Stanford 3 , Sheila J. Gross 4 Affiliation(s) 1 Merial S.A.S., Lyon, France . 2 Merial Limited, Duluth, USA . 3 Summit Ridge Farms, Susquehanna, USA . 4 26 Bayberry Close, Piscataway, USA . ABSTRACT Because of their convenience, oral dosage forms are an emerging trend in companion animal formulations. Ectoparasiticides represent a significant proportion of the treatments administered to pets, and recently oral formulations have been commercialized. They have to demonstrate high palatability to ensure that they are voluntarily accepted by the animal especially because they are repeatedly offered medications. The present study aimed to compare the dog’s preference between two commercially available oral ectoparasiticide formulations containing eith...